Entering text into the input field will update the search result below

Zynerba Pharmaceuticals' (ZYNE) CEO Armando Anido on Q2 2018 Results - Earnings Call Transcript

SA Transcripts profile picture
SA Transcripts

Zynerba Pharmaceuticals (NASDAQ:ZYNE) Q2 2018 Earnings Conference Call August 2, 2018 8:30 AM ET


Will Roberts – Investor Relations and Corporate Communications

Armando Anido – Chairman and Chief Executive Officer

Jim Fickenscher – Chief Financial Officer and Vice President of Corporate Development



Good morning and welcome to the Zynerba Pharmaceuticals’ Second Quarter 2018 Business Update Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session and instructions will follow at that time. As a remainder, today's conference call is being recorded.

I would now like to turn the call over to Will Roberts, Vice President, Investor Relations and Corporate Communications.

Will Roberts

Thank you, Tiffany. Good morning everyone, and thank you for joining us on the call this morning. We issued a press release this morning announcing our second quarter 2018 financial results and providing a company update. This press release can be found on our website under the news section.

Before we begin I would like to remind you that today's webcast contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements reflect Zynerba's current expectations regarding future events, including but not limited to statements regarding design, initiation, timing, continuation and/or progress of the company's clinical trials, and the company's ability to obtain and maintain regulatory approval for its product candidates and/or the label claims that is seeking from FDA.

Additional results may differ materially from those expressed in or implied by these statements as a result of various factors including those discussed from time-to-time in the company's filings with the Securities and Exchange Commission on Form 10-K and in our periodic filings on Form 10-Q and 8-K and other filings made with the SEC. Links to these documents are available

Recommended For You

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.